Abstract
Idiopathic dilated cardiomyopathy is a myocardial disease of unknown origin. Several causal factors are discussed. One hypothesis involves energy depriviation in the failing myocardium, and a number of arguments exist for such an energy-starving situation [22, 23]. These include the following: (a) In some studies investigating the energy state of hypertrophied and failing myocardium, a reduced content of high energy phosphates was reported [5, 39]. However, these findings were not confirmed by others [33, 34]. (b) In the failing human myocardium, a reduction in myofibrillar ATPase activity [1, 25, 30] and a shift of the isoenzyme pattern of lactate dehydrogenase [36] has been observed. Both changes may be interpreted in terms of adaptation to energy depletion; reduced myofibrillar ATPase activity is associated with more economical tension development, as shown in mammalian myocardium [2, 15, 16] and in human myocardium [14], and the shifts in the isoforms of the lactate dehydrogenase are indicators of anaerobic glycolysis [36]. (c) A reduction in capillary density may lead to increased diffusion distances [4]. (d) A reduced ratio of mitochondria and myofibrillar volumes indicates a mismatch between the number of ATP synthesizing sites and the number of ATP consuming sites [4, 31]. (e) Reduced coronary reserve has been observed in patients with dilated cardiomyopathy using the dipyridamole test [28, 29, 32].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alpert NR, Gordon MS (1962) Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol 202:940–946
Alpert NR, Mulieri LA (1982) Increasing myothermal economy of isometric force genera- tion in compensated cardiac hypertrophy induced by pulmonary artery constriction in rabbit. A characterization of heat liberation in normal and hypertrophied papillary muscle. Circ Res 50:491–500
Amin DK, Shah PK, Hulse S, Shellock FG, Swan HJC (1984) Myocardial metabolic and hemodynamic effects of intravenous MDL 17043, a new cardiotonic drug in patients with severe heart failure. Am Heart J 108:1285–1292
Anversa P, Olivetti C, Melissari M, Loud AV (1980) Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of the adult rat. J Moll Cell Cardiol 12:781–795
Bashore TM, Magorien DJ, Letterio J, Shaffer P, Unverferth DV (1987) Histologic and biochemical correlates of the left ventricular chamber dynamics in man. J Am Coll Cardiol 9:734–742
Braunwald E (1971) Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 27:416–432
Cohn JN, Archibald DG, Ziesche S et al. (1986) Effects of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314:1547–1552
CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429–1435
Dies F, Krell MJ, Whitlow P, Liang C-S, Goldenberg I, Applefeld MM, Gilbert EM (1986) Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 74 [Suppl II]:152
Dubiel IS, Dubiel IP, Frendo J, Zmudka K, Horzela T (1986) Coronary circulation and myocardial metabolism in dilated cardiomyopathy. Cor Vasa 28:356–364
Graham TP, Covell JW, Sonnenblick EH, Ross J Jr, Braunwald E (1968) Control of myocardial oxygen consumption: relative influence of contractile state and tension development. J Clin Invest 47:375–385
Hasenfuss G, Holubarsch C, Heiss HW, Bonzel T, Funfack M, Revenaugh M, Meinertz T, Just H (1987) Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilated cardiomyopathy. Clin Cardiol 10:223–327
Hasenfuss G, Holubarsch C, Heiss HW, Meinertz T, Bonzel T, Wais U, Lehmann M, Just H (1989) Myocardial energetics in patients with dilative cardiomyopathy. Influence of nitroprusside and enoximone. Circulation 80:51–64
Hasenfuss G, Mulieri LA, Blanchard EM, Holubarsch C, Leavitt BJ, Ittleman F, Alpert NR (1991) Energetics of isometric force development in control and volume-overload human myocardium. Comparison with animal species. Circ Res 68:836–846
Holubarsch C, Goulette RP, Mulieri LA, Alpert NR (1983) Heat liberation in experimentally induced tetanic contractions of myocardium from normal and Goldblatt rats. In: Jacob R (ed) Cardiac adaptation of hemodynamic overload, training and stress. Steinkopff, Darmstadt, pp 158–166
Holubarsch C, Litten RZ, Mulieri LA, Alpert NR (1985) Energetic changes of myocardium as an adaptation to chronic hemodynamic overload and thyroid gland activity. Basic Res Cardiol 80:582–593
Holubarsch C, Hasenfuss G, Heiss HW, Meinertz T, Just H (1987) Acute and chronic changes of myocardial energetics in the mammalian and human heart. Basic Res Cardiol 82 [Suppl II]:377–388
Holubarsch C, Hasenfuss G, Just H, Blanchard E, Mulieri LA, Alpert NR (1989) Influence of the positive inotropic substance pimobendane (UDCG 115 BS) on contractile economy of guinea pig papillary muscles. J Cardiovasc Pharmacol 14 [Suppl 2]:S13-S17
Holubarsch C, Hasenfuss G, Blanchard E, Mulieri LA, Alpert NR (1989) Influence of the phosphodiesterase inhibitor E-1020 on mechanics and energetics in guinea pig papillary muscles. Circulation 80 [Suppl II]:612
Holubarsch C, Hasenfuss G, Just H, Blanchard EM, Mulieri LA, Alpert NR (1990) Modulation of myothermal economy of isometric force generation by positive inotropic interventions in the guinea pig myocardium. Cardioscience 1:33–41
Holubarsch Ch, Hasenfuss G, Thiefelder L, Just H (1991) Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure. Bas Res Cardiol 86, Suppl I:107–112
Katz AM (1986) Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 73 [Suppl III]: 184–188
Katz AM (1989) Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart. Basic Res Cardiol 84 [Suppl I]:47–53
Laskey WK, Reichek N, Sutton MS, Untereker WJ, Hirshfeld JW (1983) Myocardial oxygen consumption in left ventricular hypertrophy and its relation to left ventricular mechanics. Am J Cardiol 52:852–858
Leclerque JF, Swynghedauw B (1976) Myofibrillar ATPase, DNA and hydroxyproline content of human hypertrophied heart. Eur J Clin Invest 6:27–33
Martin JL, Likoff MJ, Janicki JS, Laskey WK, Hirshfeld JW, Weber KT (1984) Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure. J Am Coll Cardiol 4:875–883
Mirsky I (1979) Elastic properties of the myocardium: a quantitative approach with physiological and clinical applications. In: Berne RM (ed) Handbook of physiology. The cardiovascular system. American Physiological Society, Washington, pp 497–531
Nitenberg A, Foult IM, Blanchet F, Zonioneche S (1985) Multifactorial determinants of reduced coronary flow reserve after dipyridanole in dilated cardiomyopathy. Am J Cardiol 55:748–754
Opherk D, Schwarz F, Mall G, Manthey J, Baller D, Kuebler W (1983) Coronary dilator capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients. Am J Cardiol 51:1657–1662
Pagani ED, Alousi AA, Grant AM, Order TM, Dziuban SW, Allen PD (1988) Changes in myofibrillar content and Mg-ATPase activity in ventricular tissue from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ Res 63:380–385
Page E, McCalister LP (1973) Quantitative electron microscopic description of heart muscle cells. Application to normal, hypertrophied, and thyroxin-stimulated heart. Am J Cardiol 31:172–181
Pasternac A, Noble J, Streulens Y, Elie R, Heuschke C, Bourassa MG (1982) Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 65:778–789
Regitz V, Rappolder M, Bossaller C, Strasser R, Fleck E (1990) Myocardial ATP, ADP and AMP in heart failure of different origins. Eur Heart J 11[Suppl]:189
Regitz V, Fleck E (1992) Adenine nucleotide metabolism and contracile dysfunction in heart failure. Basic Res Cardiol 87, Suppl I:321–329
Rooke GA, Feigl EO (1982) Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 50:273–286
Schultheiss HP (1990) Effect on the myocardial energy metabolism of angiotensin- converting enzyme inhibition in chronic heart failure. Am J Cardiol 65:G74-G81
SOLVD investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection farctions and congestive heart failure. N Engl J Med 325:293–302
Strauer BE (1979) Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44:999–1006
Swain JL, Sabina RL, Peyton RB et al. (1979) Derangements in myocardial purin and pyrimidin metabolism in patients with coronary artery disease and left ventricular hypertrophy. Proc Natl Acad Sci USA 79:655–659
Thierfelder L, Holubarsch C, Hasenfuss G, Heiss HW, Just H (1991) The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 17:593–599
von Herrath M, Hasenfuss G, Holubarsch C, Hofmann T, Heiss HW, Just H (1990) Repeated determination of left ventricular wall thickness from mass and volume during one cardiac cycle for the calculation of left ventricular wall stress parameters. Clin Cardiol 13:218–220
Viquerat CE, Kereiakes D, Morris L, Daly PA, Wexman M, Frank P, Parmley WW, Chatterjee K (1985) Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure. J Am Coll Cardiol 5:326–332
Xamoterol in Severe Heart Failure Study Group (1990) Xamoterol in severe heart failure. Lancet 336:1–6
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Holubarsch, C., Hasenfuss, G., Just, H. (1993). Myocardial Oxygen Consumption in Patients with Idiopathic Dilated Cardiomyopathy: Effects of Vasodilating and Inotropic Agents. In: Figulla, HR., Kandolf, R., McManus, B. (eds) Idiopathic Dilated Cardiomyopathy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77891-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-77891-9_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77893-3
Online ISBN: 978-3-642-77891-9
eBook Packages: Springer Book Archive